<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504292/bin/medicina-58-01229-g004.jpg"/> </div> <div class="text-side"> <h1>Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma.</h1> <p>(A) TRPV4 expression in blood vessels of tongue tissues with OSCC of animal groups treated with 4NQO. (i) H&amp;E and (ii) immunohistochemistry staining of blood vessels. (B) (iii) H&amp;E and (iv) immunohistochemistry staining of blood vessels in 4NQO group treated with GSK1016790A. Note that GSK1016790A enhanced the TRPV4 expression in blood vessel of cancerous tissue. Scale bar is 50 Âµm and magnified to 1:1.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36143906/" target="_blank">36143906</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>